Engineering

Business Development

Administrative

Operations

Media and Communication

Legal

Information Technology

Research

Human Resources

Quality Assurance

Healthcare Services

Finance

Program and Project Management

Chief Scientific Officer

Founder

Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials

Imide-based modulators of proteolysis and associated methods of use

Cereblon ligands and bifunctional compounds comprising the same

Summer Intern - Computational Chemistry & Artificial Intelligence

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. The internship project will explore approaches to ternary complex modeling and involve collaborating closely with members of the Arvinas CADD team.